Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Method validation revisited: a chemometric approach.

M J Cardone1, S A Willavize, M E Lacy

  • 1Chemistry Department, Rutgers University, Piscataway, New Jersey 08854.

Pharmaceutical Research
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.

European journal of clinical pharmacology·2008
Same author

A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects.

The Journal of antimicrobial chemotherapy·2000
Same author

The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects.

American journal of surgery·1999
Same author

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.

American journal of surgery·1999
Same author

The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects.

American journal of surgery·1999
Same author

Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1998

This study introduces a new validation procedure using corrigible error correction (CEC) to meet FDA accuracy requirements. The method quantifies systematic errors, separating them into components for better analytical method assessment.

Area of Science:

  • Analytical Chemistry
  • Method Validation
  • Biostatistics

Background:

  • Current analytical method validation often requires extensive datasets.
  • Accurate quantification of systematic error is crucial for regulatory compliance (FDA).
  • Separating error components aids in identifying sources of inaccuracy.

Purpose of the Study:

  • To present a single-dataset validation procedure meeting FDA requirements.
  • To introduce the corrigible error correction (CEC) technique for method validation.
  • To quantitatively separate and analyze systematic bias components.

Main Methods:

  • Utilized the corrigible error correction (CEC) technique.
  • Employed three response curves: standard, Youden one-sample, and method of standard additions (MOSA).

Related Experiment Videos

  • Analyzed 15-18 X,Y data pairs to assess accuracy, precision, linearity, dynamic range, and homoscedasticity.

    • Main Results:

    • The CEC technique successfully met FDA validation requirements using a single dataset.
    • Systematic bias was quantitatively separated into constant and proportional error components.
    • Constant systematic error was further resolved into system (blank) and analyte-matrix (sample) contributions.

    Conclusions:

    • The presented validation procedure provides a comprehensive assessment of analytical methods.
    • CEC facilitates the quantitative separation of systematic errors, aiding in method improvement.
    • Statistical diagnostics determine if identified errors necessitate root cause analysis or are calibration constants.